Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06172959 · ClinicalTrials.gov registry record · NA
The Short-term Impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on Respiratory Function in Patients With Lung Cancer
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT06172959: Completed NA study, sponsored by University of Miami.
NCT06172959 is a NA study that has completed, run by University of Miami. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06172959, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the short-term impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on respiratory function in patients with lung cancer. As a secondary outcome, this research will evaluate the effect of the music intervention on respiratory quality of life.
Primary Outcome
Maximum Phonation Time (MPT) measures the number of seconds a participant can sustain a phonated sound.
Interventions
- BEHAVIORAL Vocal Intonation Therapy (VIT)
- BEHAVIORAL Therapeutic Singing (TS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2024-02-21 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
What the finished NCT06172959 record still lists
NCT06172959 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Vocal Intonation Therapy (VIT) is the first listed.
NCT06172959 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06172959 about?
NCT06172959 is a clinical study titled "The Short-term Impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on Respiratory Function in Patients With Lung Cancer". The purpose of this study is to examine the short-term impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on respiratory function in patients with lung cancer. As a secondary outcome, this research will evaluate the effect of the music intervention on respiratory quality of life.
What is the current status of trial NCT06172959?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2024-02-21. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT06172959?
The interventions under investigation include: Vocal Intonation Therapy (VIT) (BEHAVIORAL), Therapeutic Singing (TS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06172959?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06172959's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI